{"id":"W2602588549","doi":"10.1182/blood.v128.22.2794.2794","title":"Relapse Following Initial Remission and Subsequent Outcome for Children with Relapsed Acute Myeloid Leukemia on the AAML0531 Phase III Study of Gemtuzumab Ozogamicin: A Report from the Children's Oncology Group","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"ca_institutions":"SickKids Foundation; Hospital for Sick Children","funders":"","keywords":"Gemtuzumab ozogamicin; Medicine; Cumulative incidence; Internal medicine; Oncology; Chemotherapy regimen; Induction chemotherapy; Univariate analysis; Chemotherapy; CD33; Surgery; Transplantation; Multivariate analysis; Stem cell","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001972577,0.0003996756,0.0005513902,0.0001689243,0.0001787268,0.0004044325,0.0003499178,0.0003339591,0.0005074457],"category_scores_gemma":[0.00101202,0.0001536652,0.0007586288,0.0002049537,0.000249038,0.0002129748,0.0002152505,0.0009086984,0.00008565356],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0006498038,"about_ca_system_score_gemma":0.000769617,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001532461,"about_ca_topic_score_gemma":0.002630376,"domain_scores_codex":[0.9994949,0.0002802383,0.00002800607,0.00005787368,0.00008703426,0.00005204066],"domain_scores_gemma":[0.998969,0.0002645271,0.0003767215,0.00005758712,0.00005411662,0.0002781494],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.1950558,0.01104257,0.6563307,0.000385277,0.003294185,0.0004382543,0.0003867617,0.003114125,0.01782371,0.0002314099,0.004368991,0.1075283],"study_design_scores_gemma":[0.03345608,0.1077552,0.8468584,0.00007711998,0.001386071,0.0008380389,0.00008477415,0.002545673,0.004679549,0.0000831324,0.002207599,0.00002813845],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9987032,0.000780883,0.00006878087,0.00006728772,0.000007496283,0.00004632121,0.0001678372,0.00000460561,0.0001535373],"genre_scores_gemma":[0.9980135,0.000437635,0.0002333188,0.000123177,0.00003036578,0.00006710486,0.0008805593,0.000003084507,0.0002112967],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001972577,"threshold_uncertainty_score":0.01043206,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.0278172505050309,"score_gpt":0.3300827856166648,"score_spread":0.3022655351116338,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}